Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...
The the US Food and Drug Administration (FDA) has approved the first medication to ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...